STERIS (STE) Competitors $248.68 +0.69 (+0.28%) Closing price 03:59 PM EasternExtended Trading$248.78 +0.10 (+0.04%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STE vs. BDX, IDXX, EW, RMD, DXCM, PODD, HOLX, BAX, GMED, and MASIShould you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry. STERIS vs. Its Competitors Becton, Dickinson and Company IDEXX Laboratories Edwards Lifesciences ResMed DexCom Insulet Hologic Baxter International Globus Medical Masimo STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations. Do insiders & institutionals have more ownership in STE or BDX? 94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to STE or BDX? In the previous week, Becton, Dickinson and Company had 26 more articles in the media than STERIS. MarketBeat recorded 37 mentions for Becton, Dickinson and Company and 11 mentions for STERIS. Becton, Dickinson and Company's average media sentiment score of 1.55 beat STERIS's score of 1.43 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 9 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 33 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is STE or BDX more profitable? STERIS has a net margin of 11.61% compared to Becton, Dickinson and Company's net margin of 7.51%. Becton, Dickinson and Company's return on equity of 16.23% beat STERIS's return on equity.Company Net Margins Return on Equity Return on Assets STERIS11.61% 14.17% 9.25% Becton, Dickinson and Company 7.51%16.23%7.46% Which has more volatility & risk, STE or BDX? STERIS has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.27, indicating that its stock price is 73% less volatile than the S&P 500. Which has higher valuation and earnings, STE or BDX? Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTERIS$5.46B4.49$614.64M$6.5338.08Becton, Dickinson and Company$21.39B2.51$1.71B$5.5633.74 Do analysts prefer STE or BDX? STERIS presently has a consensus price target of $273.50, indicating a potential upside of 9.98%. Becton, Dickinson and Company has a consensus price target of $213.30, indicating a potential upside of 13.72%. Given Becton, Dickinson and Company's higher possible upside, analysts plainly believe Becton, Dickinson and Company is more favorable than STERIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STERIS 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Becton, Dickinson and Company 0 Sell rating(s) 7 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.36 Is STE or BDX a better dividend stock? STERIS pays an annual dividend of $2.52 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.2%. STERIS pays out 38.6% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 74.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has raised its dividend for 20 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. SummarySTERIS beats Becton, Dickinson and Company on 11 of the 19 factors compared between the two stocks. Get STERIS News Delivered to You Automatically Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STE vs. The Competition Export to ExcelMetricSTERISMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$24.42B$6.78B$5.75B$21.52BDividend Yield1.02%1.20%5.89%3.50%P/E Ratio38.0826.5876.6629.87Price / Sales4.49196.29507.2653.61Price / Cash17.4021.7137.2224.68Price / Book3.694.9413.944.54Net Income$614.64M$178.07M$3.29B$999.97M7 Day Performance1.91%5.46%0.63%1.44%1 Month Performance1.29%6.81%4.32%4.66%1 Year Performance2.90%17.67%84.13%14.11% STERIS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STESTERIS4.8854 of 5 stars$248.68+0.3%$273.50+10.0%+1.8%$24.42B$5.46B38.0817,787Positive NewsAnalyst UpgradeBDXBecton, Dickinson and Company4.9522 of 5 stars$191.50-0.5%$211.44+10.4%-20.4%$55.14B$21.39B34.4474,000Positive NewsAnalyst ForecastIDXXIDEXX Laboratories4.261 of 5 stars$652.83+1.5%$649.44-0.5%+26.3%$51.44B$4.04B54.3611,000Positive NewsEWEdwards Lifesciences4.7562 of 5 stars$80.28-0.8%$85.90+7.0%+8.2%$47.52B$5.44B11.5515,800Positive NewsShort Interest ↑RMDResMed4.5951 of 5 stars$279.38+0.8%$278.36-0.4%+8.4%$40.56B$5.15B29.0110,600Positive NewsDXCMDexCom4.9746 of 5 stars$78.00-3.1%$99.89+28.1%+9.2%$31.57B$4.03B54.1710,300Positive NewsPODDInsulet4.7054 of 5 stars$349.56+0.3%$335.12-4.1%+42.0%$24.53B$2.07B106.253,900Trending NewsAnalyst ForecastHOLXHologic4.8045 of 5 stars$66.54-0.3%$78.00+17.2%-23.4%$14.85B$4.03B27.617,063Positive NewsAnalyst DowngradeBAXBaxter International4.8039 of 5 stars$24.08-1.4%$30.11+25.1%-40.7%$12.54B$10.64B-80.2538,000GMEDGlobus Medical4.7619 of 5 stars$59.37-2.0%$87.64+47.6%-17.4%$8.18B$2.52B18.885,300Positive NewsInsider TradeMASIMasimo4.7785 of 5 stars$148.79+1.1%$193.60+30.1%+25.5%$8.00B$2.15B-17.465,600Positive News Related Companies and Tools Related Companies Becton, Dickinson and Company Alternatives IDEXX Laboratories Alternatives Edwards Lifesciences Alternatives ResMed Alternatives DexCom Alternatives Insulet Alternatives Hologic Alternatives Baxter International Alternatives Globus Medical Alternatives Masimo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:STE) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Share STERIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STE Stock Alerts